Senzime AB (publ) (STO:SEZI)
4.535
+0.015 (0.33%)
At close: Feb 10, 2026
Senzime AB Revenue
Senzime AB had revenue of 26.48M SEK in the quarter ending September 30, 2025, with 52.12% growth. This brings the company's revenue in the last twelve months to 89.71M, up 62.24% year-over-year. In the year 2024, Senzime AB had annual revenue of 58.48M with 63.55% growth.
Revenue (ttm)
89.71M
Revenue Growth
+62.24%
P/S Ratio
7.92
Revenue / Employee
1.66M
Employees
54
Market Cap
710.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.48M | 22.72M | 63.55% |
| Dec 31, 2023 | 35.75M | 21.72M | 154.77% |
| Dec 31, 2022 | 14.03M | 3.05M | 27.81% |
| Dec 31, 2021 | 10.98M | 1.64M | 17.60% |
| Dec 31, 2020 | 9.34M | 2.63M | 39.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BICO Group AB | 1.78B |
| C-Rad AB | 457.60M |
| Paxman AB | 305.02M |
| Mentice AB | 275.97M |
| Bactiguard Holding AB | 225.57M |
| Sedana Medical AB | 197.61M |
| OssDsign AB | 180.16M |
| Ortoma AB | 80.92M |
Senzime AB News
- 20 days ago - Senzime Secures Major Ivy League US Hospital System Contract - Accesswire
- 7 weeks ago - Senzime's Next-Generation TetraGraph System Receives Regulatory Approval in Japan - Accesswire
- 2 months ago - Senzime Unveils the Next Set of Innovations in Neuromuscular Monitoring With the Launch of EMGINE Sirius - Accesswire
- 2 months ago - Senzime Secures Major TetraGraph Order from Leading UK NHS Hospital System - Accesswire
- 3 months ago - Senzime to Present at Redeye and BioStock Investor Conferences - Accesswire
- 3 months ago - Nomination Committee for Senzime Annual General Meeting 2026 - Accesswire
- 3 months ago - Senzime AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Senzime AB (publ) (SNZZF) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha